Navigation Links
North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
Date:8/16/2010

DALLAS, Aug. 16 /PRNewswire/ -- North American Spine is pleased to announce that Robert R. Bulger, M.D. has joined our group to help further the advancement of minimally invasive back pain treatment techniques.  The AccuraScope™ Discectomy and Neural Decompression (D.N.D.) procedure treats a variety of conditions responsible for back pain on multiple lumbar levels using one single, tiny incision. North American Spine's trained physicians are the only doctors performing the procedure in the Dallas/Fort Worth area. North American Spine plans to expand its elite group of hand-selected specialists in key locations nationwide, including Houston, TX soon, with expansion to select markets worldwide also under way.

After attending the prestigious Mayo Medical School College of Medicine, Dr. Bulger trained in both Internal Medicine and Anesthesiology at Emory University in Atlanta.  During his fellowship at Penn State, he developed epidural infusion protocols and techniques for post-operative pain that have since been adopted by numerous hospitals, including the world-renowned Cleveland Clinic.  Other honors include an invitation to be an expert panelist and lecturer at the American Society of Anesthesiology national meeting, visiting professor for the UT Southwestern Medical Center residency and a former President of the Dallas County Anesthesia Society.  Dr. Bulger has also been selected by his peers as one of D Magazine's Best Doctors in Dallas in each of the past six years.

"North American Spine and our specially trained physicians are dedicated to providing the best spine care for patients," said Sam Bailey, Ph.D., President of North American Spine. "We are excited and honored to work with a physician of Dr. Bulger's stature.  His knowledge and experience will help us continue to improve our already excellent outcomes and formalize our research studies for peer-reviewed publication."

Dr. Bulger is specially trained on the AccuraScope™ procedure which allows physicians to examine the inside of the spinal canal and the discs of the lower back to identify, diagnose and treat any tears, ruptures, herniations, bulges or other abnormalities -- many of which may be undetected or mis-identified by MRIs.

"The AccuraScope™ procedure represents a significant, yet natural evolution of proven pain management techniques," said Dr. Bulger, physician with North American Spine. "This represents the logical next step in a conservative course of treatments if the patient does not respond to traditional pain management techniques."

The AccuraScope™ procedure is a minimally invasive, natural opening procedure that allows doctors to diagnose and treat acute and chronic back pain problems. AccuraScope™ has a demonstrated track record and an unrivaled success rate with more than 5,000 patients already treated.

For more information on Dr. Bulger and North American Spine's minimally invasive procedures, please visit www.northamericanspine.com.

About North American Spine

North American Spine's revolutionary AccuraScope™ Discectomy and Neural Decompression (D.N.D.) procedure is a minimally invasive, natural opening procedure used to both diagnose and treat disc problems on multiple levels directly at their source. The procedure takes approximately 30-45 minutes with patients usually being discharged in about an hour and able to resume light physical activity the next day. It has a demonstrated track record and an unrivaled success rate with more than 5,000 patients already treated for chronic and acute back pain. North American Spine is the only group in the Dallas/Fort Worth area that performs the AccuraScope™ D.N.D. procedure and has trained physicians dedicated to providing the best spine care for patients. For more information about the AccuraScope™ D.N.D. procedure and North American Spine, please visit www.northamericanspine.com.


'/>"/>
SOURCE North American Spine
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
3. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
5. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
6. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
7. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
8. Northwestern Memorial Transplant Program Initiates New Study
9. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
10. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
11. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... ... 13, 2017 , ... While it’s often important to take certain medications during ... Austin, Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP ... such, it eliminates the need to turn on a light when taking medication during ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
Breaking Medicine News(10 mins):